Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHARLES W COATS

Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry

NPI
1982648630
CMS profile
647499
Location
INDIANAPOLIS, IN

General Payments · PY2018–2024

$1,739.06

  • Reported across 98 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$343.09

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $343.09 13

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Janssen Pharmaceuticals, Inc $123.48 1
Lundbeck LLC $78.89 5
ITI, Inc. $43.35 2
Lilly USA, LLC $32.31 2
Axsome Therapeutics, Inc. $22.89 1
Paratek Pharmaceuticals, Inc. $21.59 1
IRONWOOD PHARMACEUTICALS, INC $20.58 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $192.17 13
PY2019 $646.57 41
PY2020 $300.70 17
PY2021 $69.70 5
PY2023 $186.83 9
PY2024 $343.09 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20182019202020212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Axsome Therapeutics, Inc. $22.89 06/26/2024 Food and Beverage Undisputed 01/23/2026 1148270755 CMS
IRONWOOD PHARMACEUTICALS, INC $20.58 08/02/2024 Food and Beverage Undisputed 01/23/2026 1153736518 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.00 11/21/2024 Food and Beverage Undisputed 01/23/2026 1143209216 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.35 12/18/2024 Food and Beverage Undisputed 01/23/2026 1143209220 CMS
Janssen Pharmaceuticals, Inc $123.48 08/26/2024 Food and Beverage Undisputed 01/23/2026 1078018480 CMS
Lilly USA, LLC $16.53 05/01/2024 Food and Beverage Undisputed 01/23/2026 1136108724 CMS
Lilly USA, LLC $15.78 06/20/2024 Food and Beverage Undisputed 01/23/2026 1136101714 CMS
Lundbeck LLC $14.49 03/04/2024 Food and Beverage Undisputed 01/23/2026 1145905859 CMS
Lundbeck LLC $15.45 05/14/2024 Food and Beverage Undisputed 01/23/2026 1145905861 CMS
Lundbeck LLC $14.09 05/18/2024 Food and Beverage Undisputed 01/23/2026 1145905863 CMS
Lundbeck LLC $20.44 08/01/2024 Food and Beverage Undisputed 01/23/2026 1145905865 CMS
Lundbeck LLC $14.42 09/03/2024 Food and Beverage Undisputed 01/23/2026 1145905867 CMS
Paratek Pharmaceuticals, Inc. $21.59 10/15/2024 Food and Beverage Undisputed 01/23/2026 1113895969 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.